December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Globe Conserving Therapy in Retinoblastoma: Comparison of Time Course of Tumor Reduction for Primary Chemoreduction Versus External Beam Radiotherapy
Author Affiliations & Notes
  • DA Sussman
    Ophthalmology Bascom Palmer Eye Institute University of Miami School of Medicine Miami FL
  • EM Escalona
    Ophthalmology Bascom Palmer Eye Institute University of Miami School of Medicine Miami FL
  • MS Benz
    Ophthalmology Bascom Palmer Eye Institute University of Miami School of Medicine Miami FL
  • D Hess
    Ophthalmology Bascom Palmer Eye Institute University of Miami School of Medicine Miami FL
  • W Feuer
    Ophthalmology Bascom Palmer Eye Institute University of Miami School of Medicine Miami FL
  • N Ciciarelli
    Ophthalmology Bascom Palmer Eye Institute University of Miami School of Medicine Miami FL
  • A Markoe
    Ophthalmology Bascom Palmer Eye Institute University of Miami School of Medicine Miami FL
  • S Toledano
    Ophthalmology Bascom Palmer Eye Institute University of Miami School of Medicine Miami FL
  • TG Murray
    Ophthalmology Bascom Palmer Eye Institute University of Miami School of Medicine Miami FL
  • Footnotes
    Commercial Relationships   D.A. Sussman, None; E.M. Escalona, None; M.S. Benz, None; D. Hess, None; W. Feuer, None; N. Ciciarelli, None; A. Markoe, None; S. Toledano, None; T.G. Murray, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 2590. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      DA Sussman, EM Escalona, MS Benz, D Hess, W Feuer, N Ciciarelli, A Markoe, S Toledano, TG Murray; Globe Conserving Therapy in Retinoblastoma: Comparison of Time Course of Tumor Reduction for Primary Chemoreduction Versus External Beam Radiotherapy . Invest. Ophthalmol. Vis. Sci. 2002;43(13):2590.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:To determine the time course and extent of tumor reduction associated with systemic chemoreduction or external beam radiotherapy in the treatment of advanced intraocular retinoblastoma. Methods:Retrospective review of all children with Reese-Ellsworth stage IV-V retinoblastoma undergoing globe-conserving therapy. Systemic chemoreduction utilized carboplatin, vincristine, etoposide with or without cyclosporine A given every three weeks for 9 cycles. External beam radiotherapy utilized a relative lens sparing technique with single daily fractionation to a total dose of 4140 to 4500 cGy. Adjunctive therapy included local ablative transpupillary diode laser therapy and/or cryotherapy. Study variables were recorded at baseline and 1,2,3,4,5,6 and 12 months post-treatment. Outcome measures included tumor size, tumor volume, regression pattern, tumor recurrence, globe conservation, treatment-related complications, metastases and survival. Tumor volumes were calculated using basal area and height values as determined by ultrasound, physical examination and photographic review. Results:Thirty-eight eyes were serially evaluated for tumor response. Median follow-up was 61 months. 37/38 (97%) eyes exhibited tumor reduction and globe conservation. A mean 82% reduction in tumor volume occurred after two cycles of chemotherapy compared with a 65% reduction at a similar time-point post-radiotherapy (p<0.05). There was no statistically significant difference in tumor volume reduction between treatment modalities at 12 months follow-up. Conclusion:Retinoblastoma tumor reduction exhibits a differential time course and extent based on the applied primary treatment. Earlier tumor reduction is associated with systemic chemoreduction therapy. Combined application of multiple treatment modalities appear to enhance tumor reduction and accelerate the time course of tumor response.

Keywords: 569 retinoblastoma • 538 radiation therapy • 554 retina 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×